2-[(2-methyl-2,3-dihydro-1H-isoindol-5-yl)amino]-7-(pyrimidin-2-yl)pyrimido[4',5':4,5]pyrimido[1,2-b]indazol-5(7H)-one | 1242151-18-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶并嘧啶类
• 英文名称: 2-[(2-methyl-2,3-dihydro-1H-isoindol-5-yl)amino]-7-(pyrimidin-2-yl)pyrimido[4',5':4,5]pyrimido[1,2-b]indazol-5(7H)-one
• 英文别名: 6-[(2-Methyl-1,3-dihydroisoindol-5-yl)amino]-17-pyrimidin-2-yl-1,5,7,9,17-pentazatetracyclo[8.7.0.03,8.011,16]heptadeca-3,5,7,9,11,13,15-heptaen-2-one
• CAS: 1242151-18-3
• 化学式: C₂₅H₁₉N₉O
• 分子量: 461.486
• InChiKey: SHRRGLBOQDUUJT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  35
• 可旋转键数：
  3
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  103
• 氢给体数：
  1
• 氢受体数：
  9

文献信息

• [EN] PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE<br/>[FR] DÉRIVÉ DE PYRIMIDO-PYRIMIDO-INDAZOLE
  申请人：BANYU PHARMA CO LTD

  公开号：WO2010098367A1

  公开（公告）日：2010-09-02

  The invention is to provide a novel anticancer agent or sensitizer for cancer chemotherapy or radiotherapy. A compound of a general formula (I): wherein A means an aryl group or a heteroaryl group, or a group of a formula (a):; R1 means a -(C=O)aOb(C1-C6)alkyl group, a -(C=O)aOb(C2-C6)alkenyl group, a -(C=O)aOb(C3-C6)cycloalkyl group, an aryl group or a heteroaryl group; R2 and R3 each mean a hydrogen atom, a halogen atom, a hydroxyl group, a carboxyl group, a -(C=O)aOb(C1-C6)alkyl group or a group of -(C=O)aN(R1e)R2e; R4 means a hydrogen atom or a (C1-C6)alkyl group, and the like have an excellent Wee1-kinase-inhibitory effect, and are therefore useful in the field of medicine, especially in the field of various cancer treatments.

  这项发明是为了提供一种新型的抗癌药物或增敏剂，用于癌症化疗或放疗。通式(I)的化合物：其中A表示芳基或杂环基，或者是式(a)的基团；R1表示-(C=O)aOb(C1-C6)烷基、-(C=O)aOb(C2-C6)烯基、-(C=O)aOb(C3-C6)环烷基、芳基或杂环基；R2和R3各自表示氢原子、卤素原子、羟基、羧基、-(C=O)aOb(C1-C6)烷基或-(C=O)aN(R1e)R2e的基团；R4表示氢原子或(C1-C6)烷基等，具有优异的Wee1激酶抑制作用，因此在医学领域特别是各种癌症治疗领域中非常有用。
• PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE
  申请人：Goto Yasuhiro

  公开号：US20120134955A1

  公开（公告）日：2012-05-31

  The invention is to provide a novel anticancer agent or sensitizer for cancer chemotherapy or radiotherapy. A compound of a general formula (I): wherein A means an aryl group or a heteroaryl group, or a group of a formula (a):; R 1 means a —(C═O) a O b (C1-C6)alkyl group, a —(C═O) a O b (C2-C6)alkenyl group, a —(C═O) a O b (C3-C6)cycloalkyl group, an aryl group or a heteroaryl group; R 2 and R 3 each mean a hydrogen atom, a halogen atom, a hydroxyl group, a carboxyl group, a —(C═O) a O b (C1-C6)alkyl group or a group of —(C═O) a N(R 1e )R 2e ; R 4 means a hydrogen atom or a (C1-C6)alkyl group, and the like have an excellent Wee 1-kinase-inhibitory effect, and are therefore useful in the field of medicine, especially in the field of various cancer treatments.

  本发明提供一种新型的抗癌剂或增敏剂，用于癌症化疗或放疗。该化合物的一般式（I）如下：其中，A表示芳基或杂环基，或式（a）的基团；R1表示—（C═O）aOb（C1-C6）烷基，—（C═O）aOb（C2-C6）烯基，—（C═O）aOb（C3-C6）环烷基，芳基或杂环基；R2和R3各表示氢原子、卤素原子、羟基、羧基、—（C═O）aOb（C1-C6）烷基或—（C═O）aN（R1e）R2e基团；R4表示氢原子或（C1-C6）烷基等。该化合物具有出色的Wee 1-激酶抑制作用，因此在医学领域，特别是各种癌症治疗领域中非常有用。
• US8288396B2
  申请人：——

  公开号：US8288396B2

  公开（公告）日：2012-10-16